Melanie Kleinschek

Melanie Kleinschek is currently the Chief Scientific Officer at TRex Bio. Melanie has an extensive background in various scientific and leadership roles, including Vice President positions at Theravance Biopharma US, Inc. and Director roles at Merck. Melanie also has experience as a Senior Scientist at Schering-Plough Biopharma. Melanie holds a PhD in Immunology from Leipzig University and a DVM in Veterinary medicine from Justus Liebig University Giessen.